Medicare Part A covers fractures or osteoporosis-related injuries requiring surgery or hospitalization, while Medicare Part B covers outpatient treatments for osteoporosis, such as injectable drugs ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Individualized treatment for osteoporosis calls for a keen understanding of the patient’s frame ...

MAIA Pharmaceuticals, Inc. today announced a strategic collaboration with Asahi Kasei Pharma Corp., under which MAIA will advance Teribone™ (teriparatide) for the treatment of osteoporosis in the ...

Osteoporosis treatment following fragility fracture was associated with significantly reduced hospitalization and mortality risks among patients aged 80 years and older. After fracture at 80 years of ...

Please provide your email address to receive an email when new articles are posted on . “There is abundant evidence that men are not adequately screened for osteoporosis, and those with osteoporosis ...

Researchers at Pompeu Fabra University (UPF) have made a great leap toward predicting the risk of hip fracture among people with osteoporosis and evaluating the effectiveness of specific drugs to ...

The X-ray of a spine super-imposed on a woman’s back illustrates the importance of monitoring and treatment of osteoporosis. Women are most at risk for osteoporosis because of the sudden loss of ...

Lille, France — The American College of Physicians (ACP) has just updated its guidelines for osteoporosis treatment. Bernard Cortet, MD, PhD, chairperson of the Osteoporosis Research and Information ...

The study included 44,338 matched pairs of patients who were treated with bisphosphonates, denosumab, raloxifene, or teriparatide and those who did not receive any of these treatments. HealthDay News ...

The reduced risk for hip fracture associated with osteoporosis treatment did not differ between men vs women. Osteoporosis treatment demonstrates similar efficacy for preventing hip fracture among men ...

Purpose. Trends in the use of different treatments for osteoporosis among the civilian, ambulatory U.S. population are described. Methods. Data from the Medical Expenditure Panel Survey (MEPS) were ...